Abstract
Bisphosphonates, drug of choice in the treatment of osteoporosis, have been associated with unusual skeletal side effects such as osteonecrosis of jaw and atypical femur fractures in recent years. We report two older patients with bisphosphonate-associated atypical femur fracture from a South Australian tertiary care hospital and a brief discussion of potential diagnostic complexities in this patient population.
MeSH terms
-
Aged
-
Alendronate / adverse effects
-
Bone Density Conservation Agents / adverse effects*
-
Diphosphonates / adverse effects*
-
Etidronic Acid / adverse effects
-
Etidronic Acid / analogs & derivatives
-
Female
-
Femoral Fractures / complications
-
Femoral Fractures / diagnostic imaging
-
Femoral Fractures / etiology*
-
Humans
-
Osteoporosis, Postmenopausal / complications
-
Osteoporosis, Postmenopausal / drug therapy*
-
Radiography
-
Risedronic Acid
Substances
-
Bone Density Conservation Agents
-
Diphosphonates
-
Risedronic Acid
-
Etidronic Acid
-
Alendronate